{
  "relevance": {
    "rules": [
      {
        "rule_id": "relevance_rule_1",
        "rule_text": "All abstracts that coincides with disease area of interest (IgAN). This includes any of the provided client keywords.",
        "processing_type": "keyword_filtering",
        "include_logic": {
          "any_of": [
            {
              "categories": [
                "Clinical Trial",
                "Company",
                "Disease",
                "Endpoints",
                "Other",
                "Treatment",
                "Treatment Class"
              ],
              "field": "keywords",
              "values": [
                "PROTECT",
                "ALIGN",
                "ORIGIN 3",
                "RUBY-3",
                "NCT05799287",
                "VISONARY",
                "APPLAUSE",
                "Novartis",
                "Roche",
                "Travere Therapeutics",
                "Otsuka",
                "Vera Therapeutics",
                "Alpine Immune Sciences",
                "Vertex Pharmaceuticals",
                "Remegen",
                "IgA Nephropathy",
                "Proteinuria; OR UPCR",
                "UACR",
                "eGFR",
                "KDIGO",
                "Remission",
                "Disease modification",
                "IgA-IgG immune complexes",
                "Subgroup",
                "immunosuppression",
                "non-immunosuppression",
                "pathogenic Mechanisms",
                "B cell depletion +/- B cell activation +/- B cell targeting",
                "MEST-C",
                "treatment options",
                "Clinical Trial Endpoints",
                "Biomarkers",
                "Complement proteins +/- C3 Complement +/- C4 Complement",
                "Standard of care",
                "targeted-release formulation budesonide",
                "Telitacicept",
                "Sparsentan",
                "Iptacopan",
                "Atrasentan",
                "Zigakibart",
                "Povetacicept",
                "Sibeprenlimab",
                "Atacicept",
                "Methylprednisone +/- methylprednisolone",
                "BAFF +/- APRIL; OR APRIL alone; OR BAFF/April; OR Blys/April; OR APRIL/BLyS",
                "AT1/EDNRA antagonist? +/- ERA +/- endothelian receptor antagonist",
                "Complement Factor B inhibitor +/- alternative pathway +/- complement inhibition +/- complement system inhibitors",
                "ENDR Antagonist",
                "Systemic steroid +/- Systemic glucocorticoid +/- Systemic corticosteroid",
                "SGLT2 +/- inhibition",
                "optimized supportive care +/- ACE/ARB +/- RASi +/- RAASi",
                "Gd-IgA OR IgA1 OR Gd-IgA1 OR Galactose deficient",
                "Chinook Therapeutics",
                "Immune Complex",
                "budesonide",
                "prednisone",
                "TRF budesonide",
                "Veloxis",
                "Asahi Kasei",
                "Tarpeyo",
                "Kinpeygo"
              ]
            }
          ]
        },
        "exclude_logic": ""
      }
    ]
  },
  "priorities": {
    "Very High": {
      "rules": [
        {
          "rule_id": "very_high_rule_1",
          "rule_text": "Assigned by the Calliditas team",
          "processing_type": "none",
          "include_logic": "",
          "exclude_logic": ""
        }
      ]
    },
    "High": {
      "rules": [
        {
          "rule_id": "high_rule_1",
          "rule_text": "All relevant abstracts that include any of the following: Phase 2/3 data (including meta-analyses), real-world data (including patient reported outcomes, retrospective analyses and registry data)",
          "processing_type": "context_filtering",
          "include_logic": {
            "any_of": [
              {
                "categories": ["Study Type", "Data Source"],
                "field": "keywords",
                "values": [
                  "Phase 2",
                  "Phase II",
                  "Phase 3",
                  "Phase III",
                  "meta-analyses",
                  "real-world data",
                  "patient reported outcomes",
                  "retrospective analyses",
                  "registry data"
                ]
              }
            ]
          },
          "exclude_logic": ""
        }
      ]
    },
    "Internal": {
      "rules": [
        {
          "rule_id": "internal_rule_1",
          "rule_text": "Calliditas sponsored studies",
          "processing_type": "keyword_filtering",
          "include_logic": {
            "any_of": [
              {
                "categories": ["Company"],
                "field": "keywords",
                "values": ["Calliditas"]
              }
            ]
          },
          "exclude_logic": ""
        }
      ]
    },
    "Medium": {
      "rules": [
        {
          "rule_id": "medium_rule_1",
          "rule_text": "All relevant abstracts that include any of the following: Phase 1 data, general HEOR studies, prognostic studies, preclinical studies, other general studies",
          "processing_type": "context_filtering",
          "include_logic": {
            "any_of": [
              {
                "categories": ["Study Type", "Study Category"],
                "field": "keywords",
                "values": [
                  "Phase 1",
                  "Phase I",
                  "HEOR",
                  "health economics and outcomes research",
                  "prognostic studies",
                  "preclinical studies"
                ]
              }
            ]
          },
          "exclude_logic": ""
        }
      ]
    },
    "Low": {
      "rules": [
        {
          "rule_id": "low_rule_1",
          "rule_text": "All relevant abstracts that only have mention of an indication of interest and does not include any other data",
          "processing_type": "hybrid_filtering",
          "include_logic": {
            "any_of": [
              {
                "categories": ["Disease"],
                "field": "keywords",
                "values": ["IgA Nephropathy"]
              }
            ]
          },
          "exclude_logic": ""
        }
      ]
    }
  }
}
